19,966 Shares in Humana Inc. $HUM Acquired by Investment Management Associates Inc. ADV

Investment Management Associates Inc. ADV bought a new position in Humana Inc. (NYSE:HUM) during the 3rd quarter, Holdings Channel reports. The institutional investor bought 19,966 shares of the insurance provider’s stock, valued at approximately $5,195,000. Humana accounts for approximately 1.5% of Investment Management Associates Inc. ADV’s investment portfolio, making the stock its 18th biggest position.

A number of other hedge funds have also recently made changes to their positions in the company. Elevation Point Wealth Partners LLC bought a new position in shares of Humana in the second quarter worth $32,000. Mather Group LLC. bought a new stake in Humana during the third quarter valued at $34,000. Private Wealth Management Group LLC grew its position in Humana by 47.5% during the third quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock worth $39,000 after buying an additional 48 shares in the last quarter. AlphaCore Capital LLC bought a new position in Humana in the 2nd quarter worth about $39,000. Finally, SJS Investment Consulting Inc. raised its holdings in shares of Humana by 19,300.0% in the 3rd quarter. SJS Investment Consulting Inc. now owns 194 shares of the insurance provider’s stock valued at $50,000 after acquiring an additional 193 shares in the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Stock Down 4.4%

Shares of NYSE HUM opened at $181.10 on Wednesday. The stock has a market capitalization of $21.78 billion, a P/E ratio of 16.97, a PEG ratio of 1.57 and a beta of 0.44. Humana Inc. has a one year low of $180.89 and a one year high of $315.35. The firm’s 50 day simple moving average is $249.25 and its two-hundred day simple moving average is $262.36. The company has a debt-to-equity ratio of 0.68, a current ratio of 2.02 and a quick ratio of 2.02.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on HUM. Sanford C. Bernstein reissued an “outperform” rating and set a $344.00 price objective on shares of Humana in a report on Tuesday, January 6th. Wells Fargo & Company lowered shares of Humana from an “overweight” rating to a “cautious” rating in a research report on Wednesday, January 7th. Weiss Ratings reissued a “sell (d+)” rating on shares of Humana in a research note on Thursday, January 22nd. Robert W. Baird lowered their price objective on shares of Humana from $280.00 to $264.00 and set a “neutral” rating on the stock in a research report on Thursday, December 11th. Finally, The Goldman Sachs Group cut their target price on shares of Humana from $235.00 to $215.00 and set a “sell” rating for the company in a research report on Monday, November 24th. Eight investment analysts have rated the stock with a Buy rating, nine have issued a Hold rating and five have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $293.21.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.